Topiramate 25 mg Capsules Under Fasting Conditions
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the rate and extent of absorption of topiramate 25
mg capsules (test) versus Topamax® (reference) administered as 2 x 25 mg capsules under
fasting conditions.